These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
404 related articles for article (PubMed ID: 35753323)
1. Continuing, reducing, switching, or stopping antipsychotics in individuals with schizophrenia-spectrum disorders who are clinically stable: a systematic review and network meta-analysis. Ostuzzi G; Vita G; Bertolini F; Tedeschi F; De Luca B; Gastaldon C; Nosé M; Papola D; Purgato M; Del Giovane C; Correll CU; Barbui C Lancet Psychiatry; 2022 Aug; 9(8):614-624. PubMed ID: 35753323 [TBL] [Abstract][Full Text] [Related]
2. Antipsychotic dose reduction compared to dose continuation for people with schizophrenia. Rodolico A; Siafis S; Bighelli I; Samara MT; Hansen WP; Salomone S; Aguglia E; Cutrufelli P; Bauer I; Baeckers L; Leucht S Cochrane Database Syst Rev; 2022 Nov; 11(11):CD014384. PubMed ID: 36420692 [TBL] [Abstract][Full Text] [Related]
3. Standard versus reduced dose of antipsychotics for relapse prevention in multi-episode schizophrenia: a systematic review and meta-analysis of randomised controlled trials. Højlund M; Kemp AF; Haddad PM; Neill JC; Correll CU Lancet Psychiatry; 2021 Jun; 8(6):471-486. PubMed ID: 34023019 [TBL] [Abstract][Full Text] [Related]
5. Long-acting injectable versus oral antipsychotics for the maintenance treatment of schizophrenia: a systematic review and comparative meta-analysis of randomised, cohort, and pre-post studies. Kishimoto T; Hagi K; Kurokawa S; Kane JM; Correll CU Lancet Psychiatry; 2021 May; 8(5):387-404. PubMed ID: 33862018 [TBL] [Abstract][Full Text] [Related]
6. Withdrawal versus continuation of chronic antipsychotic drugs for behavioural and psychological symptoms in older people with dementia. Declercq T; Petrovic M; Azermai M; Vander Stichele R; De Sutter AI; van Driel ML; Christiaens T Cochrane Database Syst Rev; 2013 Mar; (3):CD007726. PubMed ID: 23543555 [TBL] [Abstract][Full Text] [Related]
7. Comparative efficacy, tolerability, and acceptability of pharmacological interventions for the treatment of children, adolescents, and young adults with Tourette's syndrome: a systematic review and network meta-analysis. Farhat LC; Behling E; Landeros-Weisenberger A; Levine JLS; Macul Ferreira de Barros P; Wang Z; Bloch MH Lancet Child Adolesc Health; 2023 Feb; 7(2):112-126. PubMed ID: 36528030 [TBL] [Abstract][Full Text] [Related]
8. Efficacy and safety of long-acting injectable Vita G; Tavella A; Ostuzzi G; Tedeschi F; De Prisco M; Segarra R; Solmi M; Barbui C; Correll CU Ther Adv Psychopharmacol; 2024; 14():20451253241257062. PubMed ID: 38831918 [TBL] [Abstract][Full Text] [Related]
9. Comparative efficacy and tolerability of 32 oral and long-acting injectable antipsychotics for the maintenance treatment of adults with schizophrenia: a systematic review and network meta-analysis. Schneider-Thoma J; Chalkou K; Dörries C; Bighelli I; Ceraso A; Huhn M; Siafis S; Davis JM; Cipriani A; Furukawa TA; Salanti G; Leucht S Lancet; 2022 Feb; 399(10327):824-836. PubMed ID: 35219395 [TBL] [Abstract][Full Text] [Related]
12. An open, large, 6-month naturalistic study of outcome in schizophrenic outpatients, treated with olanzapine. Krzystanek M; Krupka-Matuszczyk I Hum Psychopharmacol; 2011 Jan; 26(1):81-5. PubMed ID: 23055416 [TBL] [Abstract][Full Text] [Related]
17. Risperidone versus typical antipsychotic medication for schizophrenia. Hunter RH; Joy CB; Kennedy E; Gilbody SM; Song F Cochrane Database Syst Rev; 2003; (2):CD000440. PubMed ID: 12804396 [TBL] [Abstract][Full Text] [Related]
18. Efficacy and effectiveness of antipsychotics in schizophrenia: network meta-analyses combining evidence from randomised controlled trials and real-world data. Efthimiou O; Taipale H; Radua J; Schneider-Thoma J; Pinzón-Espinosa J; Ortuño M; Vinkers CH; Mittendorfer-Rutz E; Cardoner N; Tanskanen A; Fusar-Poli P; Cipriani A; Vieta E; Leucht S; Tiihonen J; Luykx JJ Lancet Psychiatry; 2024 Feb; 11(2):102-111. PubMed ID: 38215784 [TBL] [Abstract][Full Text] [Related]
19. Comparative efficacy and tolerability of 32 oral antipsychotics for the acute treatment of adults with multi-episode schizophrenia: a systematic review and network meta-analysis. Huhn M; Nikolakopoulou A; Schneider-Thoma J; Krause M; Samara M; Peter N; Arndt T; Bäckers L; Rothe P; Cipriani A; Davis J; Salanti G; Leucht S Lancet; 2019 Sep; 394(10202):939-951. PubMed ID: 31303314 [TBL] [Abstract][Full Text] [Related]
20. Maintenance Treatment With Antipsychotic Drugs in Schizophrenia: A Cochrane Systematic Review and Meta-analysis. Ceraso A; Lin JJ; Schneider-Thoma J; Siafis S; Heres S; Kissling W; Davis JM; Leucht S Schizophr Bull; 2022 Jun; 48(4):738-740. PubMed ID: 35556140 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]